company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14646000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14646000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,118000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,292000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2348000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,50073000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,38185000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,38233000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50785000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11250000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39535000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39535000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1301000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,689000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-612000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-612000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1914000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11287000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11287000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,119000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,539000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1532000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1939000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7158000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7156000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4649000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28985000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24312000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24312000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1326000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,724000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-602000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-602000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16554000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,334000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11603000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11603000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,120000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,331000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2216000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5721000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14657000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14657000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28705000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58980000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30275000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30275000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1349000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,439000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-910000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-910000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 06:13:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14708000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7568000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7568000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,120000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,319000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1577000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-526000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6078000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6078000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9620000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13044000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,269000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3693000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3693000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-862000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-849000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-849000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3234000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4580000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4580000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,108000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,243000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1344000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2525000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5410000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5410000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5412000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8500000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3088000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3088000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-205000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-205000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-205000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2527000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4307000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4307000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,95000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,168000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1317000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-331000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3058000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3058000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29304000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13250000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,70000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15984000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15984000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,86918000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86918000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86918000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,67876000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,29000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10414000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10414000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,194000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1556000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-293000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8874000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8874000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37486000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17994000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19492000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19492000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,62000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,62000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,62000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 06:13:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28304000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16661000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16661000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,77000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,151000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2002000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1516000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12915000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12878000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21423000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27575000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,365000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6517000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6517000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,282000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,282000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,282000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6079000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30564000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30564000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,76000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,81000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1853000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9323000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19231000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19231000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1227000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7775000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6548000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6548000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1374000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1374000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1374000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11309000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32455000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32455000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,77000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,74000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2015000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2967000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27322000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27359000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18785000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11867000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6918000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6918000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,56552000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,56552000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,56552000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22275000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19368000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19368000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,76000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,179000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2366000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6029000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22776000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22776000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18577000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29965000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11388000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11388000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,110000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,110000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,110000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 14:16:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11278000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18246000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18246000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,219000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2878000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3610000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18756000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18756000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4844000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11935000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7091000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7091000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,424000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,424000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,424000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11241000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18572000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18572000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,157000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3287000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1768000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13355000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13355000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-121000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4010000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9958000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5827000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5827000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,445000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,445000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,445000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7083000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21485000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21485000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5555000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15930000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15930000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-519000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58216000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13153000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45582000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45582000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,110545000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,358000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,110903000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,110903000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,49391000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24898000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24898000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,222000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4654000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1930000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21944000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21944000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50115000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11250000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38893000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38893000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,279000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,279000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,279000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 12:11:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-60558000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24507000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24507000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2124000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2912000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2490000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21923000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21923000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-63000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1263000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16395000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15069000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15069000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,398000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,398000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,398000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6456000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11273000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11273000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1158000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3987000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31934000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15475000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15475000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-84000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13447000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,65201000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,51670000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,51670000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1056000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1056000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1056000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,37251000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,607000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,607000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2753000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7663000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,80477000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,86170000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,86170000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65565000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14350000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51286000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51286000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1001000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1001000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1001000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35885000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3119000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17233000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17233000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,51000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,260000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5100000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7827000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19649000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19649000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37594000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25100000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12505000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12505000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2986000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2986000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2986000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q1,2015-01-01,2015-03-31,2015-05-08 12:11:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29168000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22504000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22504000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,251000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5836000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1831000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14534000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14534000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19387000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29224000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9837000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9837000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1207000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1207000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1207000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3490000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11141000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11141000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,54000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,183000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1972000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7191000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1741000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1741000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-220000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26883000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51034000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23931000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23931000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59837000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59837000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59837000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,655000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,82682000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17809000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17809000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,69000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6590000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7465000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18549000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18549000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-307000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35731000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,56197000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20159000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20159000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,229000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,229000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,229000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-684000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1155000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3163000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,28000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22348000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22348000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,78000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,65000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1474000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4873000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25604000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25604000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-228000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-188600000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23033000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-60000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-225795000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-225795000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,120000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,3343000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41036000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,164379000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,164379000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-435000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q1,2016-01-01,2016-03-31,2017-05-11 18:10:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-87455000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25230000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25230000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,116000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,39000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-6274000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3716000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27633000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27633000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-60000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-179000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38102000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,60000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37865000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37865000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,103000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,103000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,103000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-129000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10206000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,47663000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47663000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,116000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1504000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-82999000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10947000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22769000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22769000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-435000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19470000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18985000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18985000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,38000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3746000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24609000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24609000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,118000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1944000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-16480000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5320000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33707000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33707000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3069000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,165230000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-10001000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-90228000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,61888000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,61888000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9974000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,49000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9925000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9925000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-189000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18067000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3221000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1347000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-69087000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-69087000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,117000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2004000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16361000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,669000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-49936000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-49936000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3414000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51500000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,48086000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,48086000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1074000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12900000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13974000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-13974000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q1,2017-01-01,2017-03-31,2017-05-11 18:10:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15838000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30518000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30518000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,115000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1983000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9059000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2641000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40120000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40120000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89962000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,38000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,38000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,47000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,47000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,47000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,44000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39991000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,175000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20829000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20829000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,112000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1966000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,376000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2094000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16281000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16281000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24998000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24998000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24998000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-301000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,391000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,90000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,90000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,105000.0
Orexigen Therapeutics Inc,OREX,5493008EJF1IXC1DOC52,0001382911,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8912000.0
